Annals of Ayurvedic Medicine Service by

Home Journal Issues Guide for Authors Editorial Board About Journal Aims & Scope News & Announcements


Original Research Open Access
AAM. 2012; 1(3): 71-76


Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients

Hossein Karkamandi, Seyed-Mostafa Hosseini-zijoud, Javad Hosseini.

Cited by (2)

Abstract
Aim: Immune system-related factors are important in pathogenesis of multiple sclerosis IP-10 as CXC chemokines are involved in the immune responses. Hence, this study was to investigate the association between multiple sclerosis and serum level of IP-10.
Methods: In this experimental study, blood samples were collected from 100 multiple sclerosis patients and 100 healthy controls on EDTA pre-coated tubes. Demographic data were also collected by a questionnaire which was designed specifically for this study.
Results: Our results showed that serum level of IP-10 was significantly higher in the patients than healthy controls.
We are also showed that relapsing remitting multiple sclerosis )RRMS( patients with a good economical status had elevated IP-10(CXCL10) in compare to median group (P

Key words: Multiple sclerosis, IP-10(CXCL10), Polymorphism, chemokine.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Hossein Karkamandi
Articles by Seyed-Mostafa Hosseini-zijoud
Articles by Javad Hosseini
on Google
on Google Scholar
Article Statistics
 Viewed: 2567
Downloaded: 555
Cited: 2


REFERENCES
1. O'Keeffe, J., et al., T-cells expressing natural killer (NK) receptors are altered in multiple sclerosis and responses to alpha-galactosylceramide are impaired. J Neurol Sci, 2008. 275(1-2): p. 22-8. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
2. Lindvall, O. and Z. Kokaia, Stem cells for the treatment of neurological disorders. Nature, 2006. 441(7097): p. 1094-6. [DOI via Crossref]    [Pubmed]   
3. Baker, B.J., L.N. Akhtar, and E.N. Benveniste, SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol, 2009. 30(8): p. 392-400. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
4. Dickinson, J.L., et al., Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler, 2009. 15(5): p. 563-70. [DOI via Crossref]    [Pubmed]   
5. Gholamhossein Hassanshahi, M.E.r., Ali Shamsizadeh, Mehdi Mahmoodi, Ali Mousavi, Alan James Dickson, Expression of regulated oncogen-alpha by primary hepatocytes following isolation and heat shock stimulation. Iranian Journal of Biotechnology, 2009. 7(1): p. 1-9.
6. Varley, C.L., et al., Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes. Cytokine, 2003. 23(3): p. 64-75. [DOI via Crossref]   
7. Mohammad Kazemi Arababadi, G.H., hossein Azin, Vajihe Akbarpour Salehabad, Majid Arasteh, Reza Pourali and Zohre Nekhei, No association between CCR5-Δ32 mutation and multiple sclerosis in patients of southeastern Iran. Lab Medicine, 2010. 41: p. 31-33. [DOI via Crossref]   
8. Li, M. and R.M. Ransohoff, Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol, 2008. 84(2): p. 116-31. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
9. Klein, R.S. and J.B. Rubin, Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. Trends Immunol, 2004. 25(6): p. 306-14. [DOI via Crossref]    [Pubmed]   
10. Scarpini, E., et al., IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease. J Neurol Sci, 2002. 195(1): p. 41-6. [DOI via Crossref]   
11. Fife, B.T., et al., CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol, 2001. 166(12): p. 7617-24. [Pubmed]   
12. Hassanshahi, G., et al., Expression of CXC chemokine IP-10/Mob-1 by primary hepatocytes following heat shock. Saudi Med J, 2007. 28(4): p. 514-8. [Pubmed]   
13. Azin, H., et al., The SDF-1 3'A Genetic Variation of the Chemokine SDF-1alpha (CXCL12) in Parallel with its Increased Circulating Levels is Associated with Susceptibility to MS: A Study on Iranian Multiple Sclerosis Patients. J Mol Neurosci, 2011. [Pubmed]   
14. Nakajima, H., et al., Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis. Eur Neurol, 2004. 52(3): p. 162-8. [DOI via Crossref]    [Pubmed]   
15. Hassanshahi, G., et al., Expression of IP-10 chemokine is regulated by pro-inflammatory cytokines in cultured hepatocytes. Iran J Allergy Asthma Immunol, 2007. 6(3): p. 115-21. [Pubmed]   

This Article Cited By the following articles

The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis.
Neuroimmunomodulation 2014; 21(6): 322-30.

1
 
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis
Neuroimmunomodulation 2014; 21(6): 322-330.

2
 

How to Cite this Article
Pubmed Style

Karkamandi H, Hosseini-zijoud S, Hosseini J. Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients. AAM. 2012; 1(3): 71-76.



Web Style

Karkamandi H, Hosseini-zijoud S, Hosseini J. Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients. www.scopemed.org/?mno=18969 [Access: November 18, 2017].



AMA (American Medical Association) Style

Karkamandi H, Hosseini-zijoud S, Hosseini J. Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients. AAM. 2012; 1(3): 71-76.



Vancouver/ICMJE Style

Karkamandi H, Hosseini-zijoud S, Hosseini J. Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients. AAM. (2012), [cited November 18, 2017]; 1(3): 71-76.



Harvard Style

Karkamandi, H., Hosseini-zijoud, S. & Hosseini, J. (2012) Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients. AAM, 1 (3), 71-76.



Turabian Style

Karkamandi, Hossein, Seyed-Mostafa Hosseini-zijoud, and Javad Hosseini. 2012. Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients. Annals of Ayurvedic Medicine, 1 (3), 71-76.



Chicago Style

Karkamandi, Hossein, Seyed-Mostafa Hosseini-zijoud, and Javad Hosseini. "Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients." Annals of Ayurvedic Medicine 1 (2012), 71-76.



MLA (The Modern Language Association) Style

Karkamandi, Hossein, Seyed-Mostafa Hosseini-zijoud, and Javad Hosseini. "Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients." Annals of Ayurvedic Medicine 1.3 (2012), 71-76. Print.



APA (American Psychological Association) Style

Karkamandi, H., Hosseini-zijoud, S. & Hosseini, J. (2012) Genetic variation at the CXC chemokine IP-10(CXCL10) in parallel with its increased serum level in south-eastern Iranian multiple sclerosis patients. Annals of Ayurvedic Medicine, 1 (3), 71-76.



AUTHOR LOGIN

REVIEWER LOGIN

(Review Guidelines)

Indexed In

Index Copernicus

Index Scholar

Google Scholar,

DHARA

DOAJ ( In Process)

Ayush Research Portal 

Directory of Research Journals Indexing (DRJI )

Universal Impact Factor (UIF)

Listed In

UGC approved journals list (2017)

The articles in Annals of Ayurvedic Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

 

 

 

 

An Official Journal of 

 

IASTAM member logo

 



The articles in Annals of Ayurvedic Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.